Thermosensitive cyclotriphosphazene-platinum complex conjugate, its preparation method and anticancer agent containing the same
A cyclotriphosphazene and conjugate technology, which is applied in the field of cyclotriphosphazene-platinum composite conjugates, can solve the problems of high toxicity, limited use, low anticancer activity and the like
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0033] {NP[(OCH 2 CH 2 ) 2 OCH 3 ][L-Asp·Pt(dmpda)] 3 preparation of
[0034] Will {NP[(OCH 2 CH 2 ) 2 OCH 3 ][NHCH(CH 2 COOC 2 h 5 )COOC 2 h 5 ]} 3 (1.00g, 0.95mmol) was dissolved in methanol (50ml), and the temperature of the reaction vessel was controlled at 0-5°C with an ice-water bath. Slowly add the solution containing excess Ba(OH) under stirring 2 ·8H 2O (1.19 g, 3.78 mmol) in methanol. The ice-water bath was removed after 30 minutes, and the reaction was continued for 3 hours. The reaction mixture was concentrated under reduced pressure until only a small amount of solvent remained. Excess ether or hexane was added to the concentrated reaction mixture to cause precipitation of the hydrolyzate. The precipitate thus obtained is redissolved in a small amount of methanol and then reprecipitated by adding excess ether or hexane. After the precipitation process was repeated 2-3 times, the final precipitate was vacuum-dried to obtain 0.99 g of cyclotripho...
Embodiment 2
[0048] {NP[(OCH 2 CH 2 ) 2 OCH 3 ][L-Asp·Pt(dach)]} 3 preparation of
[0049] Use {NP[(OCH 2 CH 2 ) 2 OCH 3 ][NHCH(CH 2 COOC 2 h 5 )COOC 2 h 5 ]} 3 (0.73g, 0.69mmol), Ba(OH) 2 ·8H 2 O (0.87g, 2.76mmol), cyclotriphosphazene-barium salt (0.69g, 0.61mmol), and (dach)PtSO 4 (0.63g, 1.83mmol), obtain the final conjugated product {NP[(OCH 2 CH 2 ) 2 OCH 3 ][L-Asp·Pt(dach)]} 3 (1.05 g, 95.5% yield).
[0050] Molecular formula: C 45 h 87 N 12 o 21 P 3 Pt 3
[0051] Elemental analysis (%): C, 29.01; H, 4.79; N, 9.39; P, 5.01; Pt, 30.95
[0052] Theoretical values: C, 29.85; H, 4.84; N, 9.28; P, 5.13; Pt, 32.33
[0053] Proton NMR spectroscopy (D 2 O, ppm):
[0054] δ1.1-1.4(b, 4H,
[0055] δ1.5-1.7(b, 2H,
[0056] δ2.0-2.2(b, 2H,
[0057] δ2.3-2.5(b, 2H,
[0058] Phosphorus NMR spectroscopy (D 2 O, ppm): δ34-44
[0059] Lower critical solution temperature: 92.0°C.
Embodiment 3
[0061] {NP[(OCH 2 CH 2 ) 2 OCH 3 ][L-Asp·Pt(dmach)]} 3 preparation of
[0062] Use {NP[(OCH 2 CH 2 ) 2 OCH 3 ][NHCH(CH 2 COOC 2 h 5 )COOC 2 h 5 ]} 3 (0.82g, 0.78mmol), Ba(OH) 2 ·8H 2 O (0.87g, 2.76mmol), cyclotriphosphazene-barium salt (0.74g, 0.65mmol), and (dmach)PtSO 4 (0.72g, 1.96mmol), obtain the final conjugated product according to the same method as in Example 1, {NP[(OCH 2 CH 2 ) 2 OCH 3 ][L-Asp·Pt(dmach)]} 3 (0.97 g, 78.2% yield).
[0063] Molecular formula: C 51 h 99 N 12 o 21 P 3 Pt 3
[0064] Elemental analysis (%): C, 30.22; H, 5.15; N, 8.80; P, 4.82; Pt, 29.05
[0065] Theoretical values: C, 32.33; H, 5.27; N, 8.87; P, 4.90; Pt, 30.89
[0066] Proton NMR spectroscopy (D 2 O, ppm):
[0067] δ1.3-1.6(b, 10H, H 2 NCH 2 C(C 5 h 10 )CH 2 NH 2 ),
[0068] δ2.4-2.8(b, 6H, H 2 NCH 2 C(C 5 h 10 )CH 2 NH 2 ,-NHCH(CH 2 COO)COO),
[0069] δ3.4(s, 3H, -O(CH 2 CH 2 O) 2 CH 3 ),
[0070] δ3.6-3.8(b,6H,-OCH 2 CH 2 OCH 2 CH ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com